Core Viewpoint - The China Securities Index for Hong Kong Stock Connect in the healthcare sector has shown significant growth, with a year-to-date increase of 49.37% [1]. Group 1: Index Performance - The China Securities Index for Hong Kong Stock Connect Healthcare Composite Index (930965) rose by 0.85%, reaching 3051.69 points, with a trading volume of 18.538 billion yuan [1]. - Over the past month, the index has increased by 9.40%, and over the last three months, it has risen by 15.29% [1]. Group 2: Index Composition - The index comprises 50 liquid and large-cap healthcare companies listed under the Hong Kong Stock Connect, reflecting the overall performance of these securities [1]. - The index was established on November 14, 2014, with a base point of 3000.0 [1]. Group 3: Top Holdings - The top ten holdings in the index are as follows: - Innovent Biologics (9.96%) - WuXi Biologics (9.13%) - BeiGene (8.86%) - CanSino Biologics (5.83%) - CSPC Pharmaceutical Group (5.6%) - China Biologic Products (5.26%) - JD Health (4.73%) - 3SBio (4.07%) - Hansoh Pharmaceutical (3.15%) - Zai Lab (2.69%) [1]. Group 4: Market and Sector Allocation - The index's holdings are entirely composed of securities listed on the Hong Kong Stock Exchange, with a 100% allocation to the healthcare sector [1].
中证港股通医药卫生综合指数上涨0.85%，前十大权重包含药明生物等